Biologicals Biotalys, Novonesis Form Manufacturing and Commercialization Partnership for EVOCA NG By Biotalys|18 March 2024
Biologicals Biotalys Reports 2023 Financial Results; Partnerships, Evoca Trials Among Business Highlights By Biotalys|22 February 2024
Biologicals Biotalys Enters Into Academic Collaborations with Key Scientific Leaders in Europe and U.S. By Biotalys|8 February 2024
Biologicals Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials By Biotalys|31 May 2023
Biologicals Biotalys Achieves Significant Progress in Manufacturing Capabilities for Evoca By Biotalys|26 January 2023
Biologicals Biotalys Creates Scientific Advisory Committee with Leading Experts By Biotalys|1 December 2022
Biologicals Biotalys, Novozymes Announce Successful Evoca Feasibility Study By Novozymes | Biotalys|24 October 2022
Biologicals Biotalys, Novozymes Enter into Partnership to Expand Opportunities for Evoca By Biotalys|21 June 2022
Biologicals Biotalys’ First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product By Biotalys|31 May 2022
Biologicals Latest Field Trials Validate Strength of Biotalys’ First Biocontrol Evoca By Biotalys|19 May 2022
Biologicals Biotalys Obtains New Fungicide Resistance Class for Its First Biofungicide By Biotalys|3 May 2022
Biopesticides Biotalys’ First Biocontrol Proves Consistent, High Efficacy in Field Trial Program By Biotalys|14 May 2020